| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/02/2004 | US20040171006 Comprises nucleotide sequences coding enzymatic polypeptide treatment and prevention of cancers, nervous system, urogenital, hematological and gastro-intestinal disorders |
| 09/02/2004 | US20040171005 Codon-optimised nucleic acid coding for apoaequorin and uses thereof |
| 09/02/2004 | US20040171004 Identifying polymorphism in sodium-dependent bile acid transporter gene (SLC10A2) for diagnosing and treating liver, lipid and cardiovascular dysfunction; pharmacogenetics |
| 09/02/2004 | US20040171002 Apparatus comprising receptor immobilized flow channel for conducting and monitoring multiple binding reactions associated with parrallel flow of reactants over substrate; microarrays and biosensors |
| 09/02/2004 | US20040171001 Comprises cationic, water-soluble polythiophene derivatives, which can readily transduce oligonucleotide hybridization into a clearly interpretable optical (colorimetric, fluorescent or luminescent) or electrical signal |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170998 Identifying modulators which effect post-transcriptional intron removal from partially processed messenger RNA; screening for fungicides and/or bactericides; enzyme inhibitors |
| 09/02/2004 | US20040170996 Cytotoxic T-Lymphocyte antigen-4 or interleukin-10 polymorphisms as predictors of response to therapeutic intervention |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170994 DNA sequences for human tumour suppressor genes |
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170992 Diagnostic polymorphisms of tgf-beta1 promoter |
| 09/02/2004 | US20040170991 can be employed as a sample preparation procedure performed prior to replication; comprises treating with pohosphate solution/centrifuging; genetic engineering |
| 09/02/2004 | US20040170989 Cellular gene targets for controlling cell growth |
| 09/02/2004 | US20040170988 Modified solid carrier and DNA detection device |
| 09/02/2004 | US20040170985 Polynucleotides encoding polypeptides involved in the stress response to environmental changes in methylophilus methylotrophus |
| 09/02/2004 | US20040170984 Methods and devices for detecting printhead misalignment of an in situ polymeric array synthesis device |
| 09/02/2004 | US20040170983 comprises determining normal tissue genotype for thymidylate synthase of a patient and comparing with abnormal; for determining drug toxicity; genetic engineering |
| 09/02/2004 | US20040170982 Novel therapeutic targets in cancer |
| 09/02/2004 | US20040170981 Real-time polymerase chain reaction using large target amplicons |
| 09/02/2004 | US20040170979 Dna encoding l-ribose isomerase and uses thereof |
| 09/02/2004 | US20040170978 for drug screening anti-infective or anti-pathogenic agents, monitoring RNA metabolic events and interrupting RNA metabolism in a pathogen-specific fashion; optical density |
| 09/02/2004 | US20040170977 kits for diagnosis or prognosis of cancer or cancer-related conditions based upon methylation states; microarrays; genetic engineering |
| 09/02/2004 | US20040170976 for drug screening expression libraries for microbiocides; solid phase synthesis; genetic engineering |
| 09/02/2004 | US20040170974 for drug screening treatments for asthma/inflammatory disorders; genetic engineering; kits |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170971 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 09/02/2004 | US20040170970 Split- ubiquitin based reporter systems and methods of their use |
| 09/02/2004 | US20040170969 GRF2 binding proteins and applications thereof |
| 09/02/2004 | US20040170968 Artificial long terminal repeat vectors |
| 09/02/2004 | US20040170966 Continuous time-resolved resonance energy-transfer assay for polynucleic acid polymerases |
| 09/02/2004 | US20040170965 Mixed cell diagnostic systems |
| 09/02/2004 | US20040170963 for gene expression inhibition drugs; genetic engineering |
| 09/02/2004 | US20040170962 Single LTR lentivirus vector |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170959 Methods for identifying antiviral oligonucleotides |
| 09/02/2004 | US20040170958 Viral drug susceptibility testing |
| 09/02/2004 | US20040170957 by extracting RNA from plasma and serum, polymerase chain reaction (PCR); for simply and exactly examining the analysis of genotype for four people on one slide |
| 09/02/2004 | US20040170956 Method for identifying targeting domains and methods and compositions comprising the same |
| 09/02/2004 | US20040170954 determining the level of potentially active biological pathogens in a biological material using quantitative polymerase chain reaction (PCR) |
| 09/02/2004 | US20040170952 Reagents and methods for the detection of genes associated with the major histocompatibility complex of domestic fowl, such as chicken |
| 09/02/2004 | US20040170951 Nucleotide sequences of the nucleocapsid (NP) and phosphoprotein (P) genes of a malaysian velogenic newcastle disease virus strain AF2240 and the production of the NP and P proteins in Escherichia coli |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170644 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
| 09/02/2004 | US20040170619 contacting a nucleic acid binding polypeptide, preferably a zinc finger polypeptide, with a nucleic acid sequence in the primary cell to regulate its expression; |
| 09/02/2004 | US20040170611 culturing an autologous or allogenic dermal papilla cell in the presence of a Wnt polypeptide or a fragment or analog thereof, and grafting the cultured cell onto the skin |
| 09/02/2004 | US20040168916 Miniature device for separating and isolation biological objects and uses thereof |
| 09/02/2004 | DE10348600A1 Verwendung einer Genveränderung im humanen GNAS1-Gen zur Vorhersage von Erkrankungsrisiken, Krankheitsverläufen und zur Vorhersage des Ansprechens auf Krankheitstherapien Use of a gene in the human GNAS1 gene for the prediction of disease risk, disease progression and prediction of response to treatments |
| 09/02/2004 | DE10026789B4 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation |
| 09/02/2004 | CA2787820A1 Glycoprotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | CA2714863A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2519320A1 Method of estimating antitumor effect of histone deacetylase inhibitor |
| 09/02/2004 | CA2516553A1 Use of intronic rna to measure gene expression |
| 09/02/2004 | CA2516484A1 Methods for the prediction of suicidality during treatment |
| 09/02/2004 | CA2516371A1 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | CA2516299A1 Compositions and methods for multiplex analysis of polynucleotides |
| 09/02/2004 | CA2516290A1 Methods of diagnosis and prognosis of pancreatic cancer |
| 09/02/2004 | CA2516281A1 Modulating screening thresholds for n-hybrid screening |
| 09/02/2004 | CA2516191A1 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | CA2516138A1 Therapeutic gpcr targets in cancer |
| 09/02/2004 | CA2516130A1 Assay for the identification of protein sic inhibitor |
| 09/02/2004 | CA2516128A1 Therapeutic targets in cancer |
| 09/02/2004 | CA2516029A1 Method of measuring homocysteine |
| 09/02/2004 | CA2516013A1 Predicting graft rejection |
| 09/02/2004 | CA2515792A1 Method of monitoring genomic instability using 3d microscopy and analysis |
| 09/02/2004 | CA2515779A1 Contraceptive method and compositions related to proteasomal interference |
| 09/02/2004 | CA2514017A1 Method for determining susceptibility to schizophrenia |
| 09/02/2004 | CA2513591A1 Microarray devices having controllable reaction volume |
| 09/02/2004 | CA2498650A1 Mycobacterial diagnostics |
| 09/01/2004 | EP1452867A1 DNA specific capacity affinity sensor |
| 09/01/2004 | EP1452866A1 Sensing board |
| 09/01/2004 | EP1452857A1 Biosensor |
| 09/01/2004 | EP1452856A1 Biosensor |
| 09/01/2004 | EP1452608A1 Automated performance of polymerase chain reaction |
| 09/01/2004 | EP1452607A1 Method of selecting barley variety, barley beta-amylase gene and process for producing malt alcoholic drink |
| 09/01/2004 | EP1452606A1 Method for measurement using sodium azide |
| 09/01/2004 | EP1452605A1 Method for determining antiviral activity |
| 09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
| 09/01/2004 | EP1452599A1 Improved epitope displaying phage |
| 09/01/2004 | EP1452598A1 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 09/01/2004 | EP1452593A1 Dna synthesis promoters, dna polymerase-associated factors and utilization thereof |
| 09/01/2004 | EP1452590A1 Stereostructure of dna recombination repair enzyme and utilization thereof |
| 09/01/2004 | EP1452585A1 Gamma-glutamylcysteine-producing yeast and method of screening the same |
| 09/01/2004 | EP1452540A2 Molecular sequence of swine retrovirus and methods of use |
| 09/01/2004 | EP1452232A2 Method of treating surface of substrate used in biological reaction system |
| 09/01/2004 | EP1451590A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 09/01/2004 | EP1451589A2 Methods and apparatus for blood typing with optical bio-discs |
| 09/01/2004 | EP1451588A2 Sensitive coded detection systems |
| 09/01/2004 | EP1451587A2 Antigen panels and methods of using the same |
| 09/01/2004 | EP1451581A2 Toll-like receptor 3 signaling agonists and antagonists |
| 09/01/2004 | EP1451579A2 Method of using a non-antibody protein to detect and measure an analyte |
| 09/01/2004 | EP1451578A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 09/01/2004 | EP1451572A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 09/01/2004 | EP1451552A2 Reagents and methods useful for detecting diseases of the breast |
| 09/01/2004 | EP1451375A2 Phage ligand sensor devices and uses thereof |
| 09/01/2004 | EP1451374A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays |
| 09/01/2004 | EP1451373A1 System for detecting biological materials in a sample |
| 09/01/2004 | EP1451372A1 System and method for temperature gradient capillary electrophoresis |
| 09/01/2004 | EP1451371A1 Automated genotyping |
| 09/01/2004 | EP1451370A2 Chromosomal saturation mutagenesis |